$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000149229816000072 Filed on May 03, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$62.56M	$55.57M
YoY Change	12.57%	36.04%
Cost Of Revenue	$1.400M
YoY Change
Gross Profit	$61.10M
YoY Change
Gross Profit Margin	97.67%
Selling, General & Admin	$7.200M	$8.000M
YoY Change	-10.0%	35.59%
% of Gross Profit	11.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.77M	$14.15M
YoY Change	25.55%	51.34%
% of Gross Profit	29.08%
Operating Expenses	$25.00M	$22.10M
YoY Change	13.12%	44.44%
Operating Profit	$36.10M
YoY Change
Interest Expense	-$16.90M	-$13.90M
YoY Change	21.58%	25.23%
% of Operating Profit	-46.81%
Other Income/Expense, Net	$0.00	-$100.0K
YoY Change	-100.0%	-133.33%
Pretax Income	-$15.70M	$19.40M
YoY Change	-180.93%	-365.75%
Income Tax
% Of Pretax Income
Net Earnings	-$15.71M	$19.45M
YoY Change	-180.78%	-366.33%
Net Earnings / Revenue	-25.11%	35.0%
Basic Earnings Per Share	-$0.28	$0.29
Diluted Earnings Per Share	-$0.28	$0.28
COMMON SHARES
Basic Shares Outstanding	65.25M shares	59.19M shares
Diluted Shares Outstanding	65.25M shares	59.56M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.100M	$4.200M
YoY Change	116.67%	-2.33%
Cash & Equivalents	$9.133M	$4.171M
Short-Term Investments
Other Short-Term Assets	$119.5M	$102.3M
YoY Change	16.81%	36.04%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$128.6M	$106.5M
YoY Change	20.75%	33.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.924B	$1.633B
YoY Change	17.83%	59.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$84.20M	$6.900M
YoY Change	1120.29%	-77.45%
Total Long-Term Assets	$2.306B	$1.898B
YoY Change	21.47%	51.61%
TOTAL ASSETS
Total Short-Term Assets	$128.6M	$106.5M
Total Long-Term Assets	$2.306B	$1.898B
Total Assets	$2.434B	$2.004B
YoY Change	21.43%	50.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.30M	$23.70M
YoY Change	19.41%	-9.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$28.30M	$23.70M
YoY Change	19.41%	-53.07%
LONG-TERM LIABILITIES
Long-Term Debt	$1.398B	$1.049B
YoY Change	33.32%	24.52%
Other Long-Term Liabilities	$300.0K
YoY Change
Total Long-Term Liabilities	$1.398B	$1.049B
YoY Change	33.35%	24.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.30M	$23.70M
Total Long-Term Liabilities	$1.398B	$1.049B
Total Liabilities	$1.427B	$1.072B
YoY Change	33.04%	20.13%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$653.0K	$592.0K
YoY Change	10.3%	51.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.007B	$932.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.434B	$2.004B
YoY Change	21.43%	50.56%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$15.71M	$19.45M
YoY Change	-180.78%	-366.33%
Depreciation, Depletion And Amortization	$17.77M	$14.15M
YoY Change	25.55%	51.34%
Cash From Operating Activities	$24.73M	$24.70M
YoY Change	0.1%	1946.48%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$2.000M	-$6.200M
YoY Change	-132.26%
Cash From Investing Activities	$1.964M	-$6.237M
YoY Change	-131.49%	-95.13%
FINANCING ACTIVITIES
Cash Dividend Paid	$29.30M	$25.67M
YoY Change	14.14%	54.68%
Common Stock Issuance & Retirement, Net	-$1.274M	-$7.587M
YoY Change	-83.21%	1070.83%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$25.12M	-$76.09M
YoY Change	-66.98%	-159.95%
NET CHANGE
Cash From Operating Activities	$24.73M	$24.70M
Cash From Investing Activities	$1.964M	-$6.237M
Cash From Financing Activities	-$25.12M	-$76.09M
Net Change In Cash	$1.568M	-$57.62M
YoY Change	-102.72%	261818.18%
FREE CASH FLOW
Cash From Operating Activities	$24.73M	$24.70M
Capital Expenditures		$0.00
Free Cash Flow		$24.70M
YoY Change		-77.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65273218	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.
CY2015Q4	sbra	Allowance For Straight Line Rent AllowanceForStraightLineRent	5300000	USD
CY2016Q1	sbra	Allowance For Straight Line Rent AllowanceForStraightLineRent	5500000	USD
CY2016Q1	sbra	Business Acquisition Number Of Acquired Properties BusinessAcquisitionNumberOfAcquiredProperties	4	acquisition
CY2015Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	-100000	USD
CY2016Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	0	USD
CY2016Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	0	USD
CY2016Q1	sbra	Business Combination Contingent Consideration Liability Estimated Earn Out BusinessCombinationContingentConsiderationLiabilityEstimatedEarnOut	3200000	USD
CY2013Q1	sbra	Convertible Preferred Stock Conversion Price ConvertiblePreferredStockConversionPrice	25.00
CY2016Q1	sbra	Derivative Net Liability Position Termination Value DerivativeNetLiabilityPositionTerminationValue	1100000	USD
CY2015Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	0	USD
CY2016Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	-556000	USD
CY2015Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2016Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2015Q1	sbra	Interest Income InterestIncome	5385000	USD
CY2016Q1	sbra	Interest Income InterestIncome	5332000	USD
CY2016Q1	sbra	Investments Weighted Average Contractual Rate InvestmentsWeightedAverageContractualRate	0.101
CY2016Q1	sbra	Investments Weighted Average Effective Rate InvestmentsWeightedAverageEffectiveRate	0.101
CY2015Q4	sbra	Loan Receivable Face Value LoanReceivableFaceValue	273811000	USD
CY2016Q1	sbra	Loan Receivable Face Value LoanReceivableFaceValue	271815000	USD
CY2016Q1	sbra	Loans And Leases Receivable Effective Interest Rate LoansAndLeasesReceivableEffectiveInterestRate	0.097
CY2016Q1	sbra	Loans And Leases Receivable Fixed Interest Rate LoansAndLeasesReceivableFixedInterestRate	0.098
CY2016Q1	sbra	Loans And Leases Receivable Number Of Loans LoansAndLeasesReceivableNumberOfLoans	17	loan
CY2015Q4	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	300177000	USD
CY2016Q1	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	297508000	USD
CY2016Q1	sbra	Number Of Investment Grading Companies NumberOfInvestmentGradingCompanies	2	investment_grading_company
CY2016Q1	sbra	Numberof Investments NumberofInvestments	27	loan
CY2016Q1	sbra	Operating Leases Weighted Average Lease Expiration Period OperatingLeasesWeightedAverageLeaseExpirationPeriod	P10Y
CY2015Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2016Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2015Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2016Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2015Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	29993000	USD
CY2016Q1	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	31958000	USD
CY2015Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	29643000	USD
CY2016Q1	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	31608000	USD
CY2016Q1	sbra	Preferred Equity Investment Weighted Average Contractual Rate PreferredEquityInvestmentWeightedAverageContractualRate	0.131
CY2016Q1	sbra	Preferred Equity Investment Weighted Average Effective Rate PreferredEquityInvestmentWeightedAverageEffectiveRate	0.131
CY2016Q1	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	10	loan
CY2015Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets Net PrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	111797000	USD
CY2016Q1	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets Net PrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	119519000	USD
CY2015Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2016Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2015Q1	sbra	Proceeds From Loans Payable ProceedsFromLoansPayable	0	USD
CY2016Q1	sbra	Proceeds From Loans Payable ProceedsFromLoansPayable	69360000	USD
CY2016Q1	sbra	Real Estate Investments Joint Ventures Number RealEstateInvestmentsJointVenturesNumber	0	Investment
CY2015Q1	sbra	Tenant Fees And Services Revenue TenantFeesAndServicesRevenue	682000	USD
CY2016Q1	sbra	Tenant Fees And Services Revenue TenantFeesAndServicesRevenue	1915000	USD
CY2015Q1	sbra	Total Expenses TotalExpenses	36033000	USD
CY2016Q1	sbra	Total Expenses TotalExpenses	73144000	USD
CY2015Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	-100000	USD
CY2016Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	-5158000	USD
CY2016Q1	sbra	Variable Interest Entity Number Of Entities VariableInterestEntityNumberOfEntities	2	variable_interest_entity
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	35182000	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	28308000	USD
CY2015Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	142148000	USD
CY2016Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	187279000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7333000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9398000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1202541000	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1203390000	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3023000	USD
CY2016Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1938000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3500000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3500000	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	25000	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1261000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1300000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1200000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1221000	USD
CY2015Q4	us-gaap	Assets Assets	2468837000	USD
CY2016Q1	us-gaap	Assets Assets	2434156000	USD
CY2015Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2016Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	75450000	USD
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1954129000	USD
CY2016Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1863888000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61793000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4171000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7434000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9133000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-57622000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1568000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.41
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.39
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.41
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65182335	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65273218	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65182335	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65273218	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	652000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	653000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17905000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17776000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17894000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17808000	USD
CY2013Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1.7864	shares
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1417404000	USD
CY2016Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	598000	USD
CY2016Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	18796000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14150000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17766000	USD
CY2015Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2016Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2015Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	5619000	USD
CY2016Q1	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	2078000	USD
CY2015Q4	us-gaap	Derivative Assets DerivativeAssets	7087000	USD
CY2016Q1	us-gaap	Derivative Assets DerivativeAssets	3508000	USD
CY2015Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2016Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2015Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	1468000	USD
CY2016Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	1430000	USD
CY2015Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2016Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2015Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1468000	USD
CY2016Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1430000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	7087000	USD
CY2016Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	3508000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1468000	USD
CY2016Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1989000	USD
CY2015Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1468000	USD
CY2016Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1989000	USD
CY2015Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2016Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2015Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2016Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	559000	USD
CY2016Q1	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	1100000	USD
CY2015Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1000000	USD
CY2016Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1200000	USD
CY2015Q1	us-gaap	Dividends Common Stock DividendsCommonStock	23216000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26859000	USD
CY2015Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2016Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2015Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2016Q1	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2015Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2016Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	131000	USD
CY2015Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97840000	USD
CY2016Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	82110000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Properties Net Of Applicable Income Taxes GainLossOnSaleOfPropertiesNetOfApplicableIncomeTaxes	0	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Properties Net Of Applicable Income Taxes GainLossOnSaleOfPropertiesNetOfApplicableIncomeTaxes	-4602000	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-556000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6361000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4714000	USD
CY2015Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2016Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	29811000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	19439000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-15743000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4988000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5430000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3206000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5900000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	599000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1154000	USD
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	374028	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	13880000	USD
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	16918000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	16761000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	19459000	USD
CY2015Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13300000	USD
CY2016Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9500000	USD
CY2016Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	303423000	USD
CY2015Q4	us-gaap	Investments Investments	300177000	USD
CY2016Q1	us-gaap	Investments Investments	297508000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2015Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
CY2016Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
CY2015Q4	us-gaap	Land Land	221894000	USD
CY2016Q1	us-gaap	Land Land	216594000	USD
CY2015Q4	us-gaap	Land Improvements LandImprovements	3594000	USD
CY2016Q1	us-gaap	Land Improvements LandImprovements	3811000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	1414961000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	212874000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	207388000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	1426658000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2468837000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2434156000	USD
CY2015Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2016Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	340000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	255000000	USD
CY2016Q1	us-gaap	Line Of Credit LineOfCredit	198000000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4300000	USD
CY2016Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	6700000	USD
CY2016Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	271815000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	270184000	USD
CY2016Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	265550000	USD
CY2015Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	264229000	USD
CY2016Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	338629000	USD
CY2015Q4	us-gaap	Loans Receivable Net LoansReceivableNet	274484000	USD
CY2016Q1	us-gaap	Loans Receivable Net LoansReceivableNet	272250000	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	1398010000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1198115000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	202770000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	4612000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4458000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4310000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3139000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	106000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	74000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76086000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25122000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6237000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1964000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24701000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24726000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	19450000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-15711000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16889000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18272000	USD
CY2016Q1	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	4	acquisition
CY2015Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	498000	USD
CY2016Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1412000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	2216754000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	187182000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	225025000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	219026000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	1165259000	USD
CY2015Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	49505000	USD
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	55312000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-573000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1545000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2065000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-11000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-32000	USD
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-113000	USD
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-222000	USD
CY2015Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-100000	USD
CY2016Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2015Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	25672000	USD
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	29301000	USD
CY2015Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	130000	USD
CY2016Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5885000	USD
CY2015Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	675000	USD
CY2016Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	474000	USD
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	311000	USD
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	984000	USD
CY2015Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	7303000	USD
CY2016Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5850000	USD
CY2016Q1	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	0	USD
CY2013Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07125
CY2015Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	25.00
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5800000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2015Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2052000	USD
CY2016Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	8874000	USD
CY2015Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2016Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-7587000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-1274000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	138300000	USD
CY2015Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-42000000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-57000000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	398000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1144000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2523000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	237841000	USD
CY2016Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	242630000	USD
CY2015Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2277457000	USD
CY2016Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2166403000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2039616000	USD
CY2016Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1923773000	USD
CY2015Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	697000	USD
CY2016Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1022000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9813000	USD
CY2016Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8773000	USD
CY2015Q1	us-gaap	Revenues Revenues	55572000	USD
CY2016Q1	us-gaap	Revenues Revenues	62559000	USD
CY2013Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2015Q4	us-gaap	Secured Debt SecuredDebt	174846000	USD
CY2016Q1	us-gaap	Secured Debt SecuredDebt	175045000	USD
CY2015Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	1300000	USD
CY2016Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	1400000	USD
CY2015Q4	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2016Q1	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2918000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1818000	USD
CY2016Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	1100000	shares
CY2016Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	100000	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1053770000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1007424000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	941823000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932154000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1053876000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1007498000	USD
CY2015Q1	us-gaap	Straight Line Rent StraightLineRent	5656000	USD
CY2016Q1	us-gaap	Straight Line Rent StraightLineRent	5593000	USD
CY2015Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-1545000	USD
CY2016Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-1492000	USD
CY2015Q4	us-gaap	Unsecured Debt UnsecuredDebt	685704000	USD
CY2016Q1	us-gaap	Unsecured Debt UnsecuredDebt	686336000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59559253	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65248203	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59185225	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65248203	shares
CY2016Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the Company’s condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. As a result, certain reclassifications were made to the condensed consolidated balance sheets and condensed consolidated statements of (loss) income.</font></div></div>
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001492298-16-000072-index-headers.html	Edgar Link	pending
0001492298-16-000072-index.html	Edgar Link	pending
0001492298-16-000072.txt	Edgar Link	pending
0001492298-16-000072-xbrl.zip	Edgar Link	pending
ex102form_ofxamendedxandxr.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20160331.xml	Edgar Link	completed
sbra-20160331.xsd	Edgar Link	pending
sbra-20160331_cal.xml	Edgar Link	unprocessable
sbra-20160331_def.xml	Edgar Link	unprocessable
sbra-20160331_lab.xml	Edgar Link	unprocessable
sbra-20160331_pre.xml	Edgar Link	unprocessable
sbra10q2016q1.htm	Edgar Link	pending
sbraex1212016q1.htm	Edgar Link	pending
sbraex3112016q1.htm	Edgar Link	pending
sbraex3122016q1.htm	Edgar Link	pending
sbraex3212016q1.htm	Edgar Link	pending
sbraex3222016q1.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2016 Q1 Form 10-Q Financial Statement

#000149229816000072 Filed on May 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2016 Q1 Form 10-Q Financial Statement

#000149229816000072 Filed on May 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra